Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss from Mounjaro is real, common, and — in most cases — temporary. It typically begins six to sixteen weeks after starting treatment, peaks around months three to four, and resolves on its own once your body adjusts to the rapid shift in calorie intake and body weight. Understanding why it happens is the first step to managing it. Mounjaro (tirzepatide) is a prescription-only medicine for weight management, and like all GLP-1-based treatments, changes in the body during rapid weight loss can temporarily disrupt the normal hair-growth cycle. A prescriber will assess your full health picture at consultation, including any existing conditions that might affect hair health.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The shed most people notice on Mounjaro is called telogen effluvium. Hair follicles cycle through growth (anagen), transition (catagen) and rest (telogen) phases. Physical stressors (surgery, illness, pregnancy, and yes, rapid weight loss) can push a larger-than-usual proportion of follicles into the resting phase simultaneously. Roughly two to four months later, those resting hairs fall out together, which is why the timing can feel alarming even though the cause happened weeks earlier.
Rapid calorie restriction accelerates this process. When the body is taking in significantly fewer calories, it prioritises essential functions; hair, which is not essential to survival, can be deprioritised. This is not unique to Mounjaro, it occurs with any method of meaningful weight loss, including bariatric surgery. The NHS tirzepatide information page lists hair loss among the recognised side effects of this medicine.
Understanding the mechanism matters practically: it means the follicles themselves are almost certainly intact. The shedding is a timing event, not a sign of permanent follicle damage. Knowing that tends to lower the understandable anxiety that comes with finding more hair than usual on your pillow.
Protein is the single most actionable dietary factor. Hair is made almost entirely of keratin, a protein, so when protein intake drops, hair is one of the first things to suffer. A question our prescribers hear most weeks is whether a particular supplement will stop the shed, but for most people, the better question is whether they are eating enough protein at all.
Mounjaro significantly suppresses appetite, which is the intended effect for weight management. The practical consequence is that some people eat so little that protein falls far below the levels needed to support normal cellular turnover, including hair growth. Aiming for adequate protein at each meal (lean meat, fish, eggs, Greek yogurt, pulses) is more evidence-grounded than adding supplements when intake is adequate.
Iron deficiency is the other common contributor. If you have heavy periods, follow a plant-based diet, or have any risk factors for low iron, ask your GP for a blood test. Taking iron supplements without confirming a deficiency is not helpful and can cause its own side effects. You can read more about the link between Mounjaro and hair loss and how nutritional factors fit into the broader picture.
Gentle hair care during the shed phase reduces the number of hairs lost to breakage rather than natural cycling. Avoid very tight styles that stress the scalp, limit heat styling, and use a wide-toothed comb on wet hair. These changes do not stop telogen effluvium, but they reduce the visible severity during the peak shedding period.
Some people find that a good-quality multivitamin covering zinc, vitamin D and B vitamins supports general wellbeing during calorie restriction. The evidence base for specific hair supplements is modest, but ensuring you are not depleted across multiple micronutrients is sensible when you are eating less than usual.
Hydration also plays a role: adequate water intake supports cellular function across the body, including the scalp. Many people on Mounjaro reduce fluid intake along with food intake without realising it, and our guide on how to stop hair loss on Mounjaro covers practical steps you can take alongside staying well hydrated. If you are managing other GI symptoms alongside shedding, the nausea management guidance and tips for diarrhoea on Mounjaro may also be useful, since dehydration from those symptoms can compound the effect on hair.
The shed tends to ease naturally as weight loss slows and the body adapts, usually within three to six months of onset. Regrowth follows, typically six to twelve months after the stressor resolves, though individual variation is wide.
Not all hair loss during Mounjaro treatment is telogen effluvium. Speak to your GP or ask to be referred to a dermatologist if: the shedding is patchy or asymmetrical; you notice scaling, redness or soreness on the scalp; eyebrows or eyelashes are also thinning; the shedding began before you started treatment or more than six months in without improvement; or you have a personal or family history of alopecia areata or androgenetic alopecia. These patterns point toward causes that need separate assessment.
Severe, persistent shedding that is affecting your quality of life is also worth raising with your prescriber. Dose, timing and nutritional support can all be reviewed. You can reach our team at any time through our support contact page.
The MHRA asks patients and healthcare professionals to report any suspected side effect (including unexpected hair loss) through the Yellow Card scheme. Reporting helps the regulator build a clearer picture of real-world side-effect patterns and keeps the safety profile of tirzepatide up to date for everyone. A fuller overview of Mounjaro's side-effect profile is available on our Mounjaro side effects page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.